Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,650,209
+$1,700,217 QoQ
Shares Held
159,791
+13.2% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Tetragon Partners GP Ltd holds $10,068,699 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (56.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
159,791 | $5,650,209 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
317,877 | $4,418,490 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,650,209 | 159,791 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,949,992 | 141,172 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,688,360 | 89,612 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $447,231 | 15,632 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||